Abstract. Mammalian diaphanous-related formin 1 (mDia1) was initially identified as a Rho GTPase effector involved in the progression of various diseases, including types of cancer. However, the precise underlying molecular mechanism of mDia1-mediated cancer cell invasion remains to be elucidated. In the present study, mDia1 expression was demonstrated to be upregulated in tissues from a number of cancer types, including kidney, prostate, and breast cancer using immunohistochemical analysis. Forced expression of a constitutively active (CA) form of mDia1 induces invasion, as measured by Transwell invasion assay, of MDA-MB-231 cells, which is a highly invasive breast cancer cell line, and this effect was markedly impaired by matrix metalloproteinase (MMP)-2 silencing. Furthermore, the present study demonstrated that overexpression of the CA form of mDia1 leads to the induction of invasive ability in MCF-7 cells, which is a non-invasive breast cancer cell line, as a result of increased MMP-2 activity. Thus, the results of the current study suggest that mDia1 is an important regulator of breast cancer cell invasion and that this effect may be mediated by MMP-2 activity.
Introduction
Invasion and metastasis are key mechanisms for the spread of cancer to new tissues or organs, and are major causes of cancer-associated mortality, including in breast cancer (1) . Reorganization of cytoskeletal proteins, including actin and microtubule proteins, is important for the invasion and migration of cancer cells (2, 3) . Formin proteins are essential for the regulation of cytoskeleton remodeling (4, 5) and mammalian diaphanous-related formin 1 (mDia1), a member of the formin family, is a regulator of actin polymerization and microtubule stabilization via its formin homology 2 domain (6,7). mDia1 affects actin and microtubule dynamics; thus, it has various functions, including the regulation of adhesion, polarity, morphogenesis, intracellular trafficking of vesicles, and invasion (8) (9) (10) (11) . Although the roles of mDia1 in cytoskeleton modification have been well established, few reports have demonstrated its role in disease processes, including cancer progression.
Cancer cell invasion across tissue boundaries and metastasis via the circulatory system requires proteolytic activity to degrade extracellular matrix components. The matrix metalloproteinase (MMP) family is important in the spread of cancer to other tissues, MMPs degrade the extracellular matrix, including collagen, which is the first barrier preventing cancer invasion (12) . Due to their effects on the invasion and metastasis of cancer cells, the functions of matrix metalloproteinases have been well studied (13) (14) (15) . Among the MMPs, the expression levels of MMP-2 and MMP-9 are associated with unfavorable outcomes in various types of cancer cells, including breast cancer cells (16, 17) . Despite their importance in cancer invasion, the association between mDia1 and MMPs has not been fully elucidated.
The present study aimed to identify underlying mechanisms of mDia1 to regulate cancer cell invasion. Immunohistochemical results from the cancer tissue array demonstrated that mDia1 expression levels are increased in a number of samples originating from kidney, prostate, and breast cancer. Experiments using forced expression of the constitutively active (CA) form of mDia1 (mDia1-CA) and MMP silencing in invasive and non-invasive breast cancer cell lines demonstrated the mDia1-MMP2 signaling axis is likely to be an important regulator of breast cancer invasion. siRNA transfection. MMP-2 small interfering RNA (siRNA; sequence, 5'-AAU ACA UCG AGA CCA UGCGG-3'), MMP-9 siRNA (sequence, 5'-AAC AUC ACC UAU UGG AUC CAA-3'), and non-targeting control (mock) siRNA (sequence, 5'-AUU GUA UGC GAU CGC AGAC-3') were purchased from Genolution, Inc. (Seoul, Korea). Cells were transfected with 20 nM siRNA (unless otherwise stated) using Oligofectamine reagent according to the manufacturer's protocols.
Materials and methods

Reagents
Reverse transcription-polymerase chain reaction (PCR).
Total RNA was isolated from cells using RNAiso Plus (Takara Bio, Inc., Otsu, Japan) and cDNA was synthesized using Ex-Taq DNA Polymerase (Takara Bio, Inc.) according to the manufacturer's protocols. The conditions were 30 cycles of 94˚C for 30 sec, 55˚C for 30 sec and 72˚C for 30 sec. PCR amplification was conducted using Ex-Taq DNA Polymerase (Takara Bio, Inc.) and SYBR Premix Ex-Taq II (Takara Bio, Inc.) according to the manufacturer's protocol. The reaction was conducted in a CFX Connect™ Real-Time PCR Detection system (Bio-Rad Laboratories, Inc.), with conditions as follows: 40 cycles of 94˚C for 10 sec, 55˚C for 10 sec and 72˚C for 30 sec. Oligonucleotide sequences of primers used in the present study were as follows: Sense, 5'-GGC CCT GTC ACT CCT GAGAT-3' and antisense, 5'-GGC ATC CAG GTT ATC GGGGA-3' for MMP-2; sense, 5'-CAT AAG GAC GAC GTG AATG-3' and antisense, 5'-GAA GAA AAG CTT CTT GGAGA-3' for MMP-9; sense, 5'-GAG TCA ACG GAT TTG GTCGT-3' and antisense, 5'-TGT GGT CAT GAG TCC TTCCA-3' for GAPDH. GAPDH served as an internal control and total RNA was used as a negative control. The results of the PCR were run on agarose gels and band intensity was quantified using Quantity One software (version 4.6.2; Bio-Rad Laboratories, Inc.).
Immunohistochemistry. Formalin-fixed, paraffin-embedded tissue microarray slides from cases of kidney, breast, prostate, endometrial and thyroid cancer were de-paraffinized by incubation in a dry oven for 1 h, rehydrated with serially diluted ethanol, and blocked with normal goat serum (Vector Laboratories, Inc., Burlingame, CA, USA) at room temperature for 30 min. Antigen retrieval in tissue samples was performed by heating in a microwave on high for 5 min, medium for 5 min and low for 5 min, followed by incubation with the anti-mDia1 antibody. Subsequently, the samples were incubated with a biotinylated polyclonal horse anti-goat (dilution Gelatin zymography assay. Cells were seeded in a 35-mm dish and incubated in RPMI 1640 supplemented with 10% FBS at 37˚C for 24 h. The cells were washed, and the medium was changed to serum-free RPMI 1640. Following incubation for 24 or 48 h, the conditioned medium was centrifuged at 2,000 x g for 5 min to remove cellular debris and was normalized based on the cell number prior to electrophoresis in 10% polyacrylamide gels with 1 mg/ml gelatin (Sigma-Aldrich).
Following 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis for 90 min at 30 mA, the gels were washed 4 times for 1 h with washing buffer [10 mM Tris-HCl (pH 8.0) and 2.5% Triton X-100], rinsed with distilled water twice for 10 min, and then incubated for 20 h in the developing Statistical analysis. The differences between controls and treatment groups were analyzed by Student's t-test using Microsoft Excel software. The data were expressed as the mean ± standard deviation of three independent experiments. P<0.05 was considered to indicate a statistically significant difference.
Results and Discussion
mDia1 controls invasion of breast cancer cells via MMPs.
To compare the mDia1 protein expression levels between normal and cancer tissue samples, immunohistochemical analysis was performed using a tissue microarray chip that contained 30 healthy individuals or normal tissue adjacent to the cancer and 29 cancer tissue samples. Among the tested samples, mDia1 expression was upregulated in a number of cancers, and particularly breast cancer tissue samples (Fig. 1A) . To examine the effect of mDia1-CA overexpression on breast cancer cell invasion, highly invasive MDA-MB-231 cells were transfected with the mDia1-CA plasmid and the invasive ability was examined. As presented in Fig. 1B , forced expression of mDia1-CA resulted in higher breast cancer cell invasion than that of mock-transfected cells. As mDia1 knockdown results in decreased breast cancer cell invasion (data not shown) (18), it is likely that mDia1 is directly involved in breast cancer cell invasion. It is well known that MMPs are required to induce invasion of various cancers (19, 20) . Thus, invasion assays were performed following treatment with a general MMP inhibitor, GM6001, using MDA-MB-231 cells transfected with either mock or mDia1-CA plasmids. The invasion of MDA-MB-231 cells induced by overexpression of mDia1-CA was markedly reduced in mock-and mDia1-CA-transfected cells following GM6001 treatment (Fig. 1B) . Furthermore, gelatin zymography using conditioned media prepared from the mock-and mDia1-CA-transfected cells demonstrated that MDA-MB-231 cells secreted MMP-2 and MMP-9, and that MMP-2 activity was markedly increased by mDia1-CA overexpression (Fig. 1C) , indicating that the invasion of MDA-MB-231 cells regulated by mDia1 may be dependent on MMP activity.
MMP-2 is involved in MDA-MB-231 cell invasion via mDia1.
To investigate whether MMP activity is specifically required for mDia1-mediated cancer invasion, siRNAs for MMP-2 or MMP-9 were transfected into MDA-MB-231 cells overexpressing mDia1-CA and cell invasion was analyzed. Each siRNA decreased the transcript levels of MMP-2 and MMP-9 by >90% (Fig. 2A) . Furthermore, the results of gelatin zymography performed using the conditioned media obtained from the siRNA-transfected cells demonstrated that each siRNA specifically decreased secretion of the corresponding MMP without affecting secretion of the other MMP (Fig. 2B) . The invasive capacity of the cells overexpressing mDia1-CA was investigated by silencing MMP expression. The invasion assay demonstrated that MMP-2-silenced MDA-MB-231 cells exhibited markedly lower mDia1-CA overexpression-induced invasive capacity than MMP-9-silenced cells (Fig. 2C) . These findings suggest that mDia1 is likely involved in the regulation of MMP-2 secretion to induce invasion of breast cancer cells. To investigate whether MMP-2 secretion induced by mDia1-CA is sufficient to promote invasion of breast cancer cells, the effect of mDia1-CA expression on the activation of MMP and invasion of non-invasive breast cancer MCF-7 cells, which have lower mDia1 expression than MDA-MB-231 cells, was investigated (Fig. 3A) . Gelatin zymography using conditioned media prepared from the mock-and mDia1-CA-transfected cells demonstrated that MCF-7 cells secrete MMP-2 and MMP-9 and that forced expression of mDia1-CA significantly induced MMP-2 activity, whereas MMP-9 activity was not markedly affected (P<0.001; Fig. 3B ). The invasion assay indicated that control MCF-7 cells show little invasion into the membrane, whereas overexpression of mDia1-CA in MCF-7 cells resulted in significantly higher cell invasion than that of mock-transfected cells (P<0.001; Fig. 3C ). These results indicated that mDia1 is responsible for the invasive phenotype of breast cancer cells and MMP-2 is likely to mediate the invasion induced by mDia1.
As mDia1 regulates actin filaments, previous studies have suggested that it is key in cell invasion via the actin assembly (18, 20, 21) . It has been reported that an actin-binding protein, cortactin, modulates the secretion and membrane expression of invadopodium-associated MMPs, including MMP-2 and MMP-9 in various cell types, such as vascular smooth muscle cells, head and neck squamous cell carcinomas, and breast cancer cells (22) . As knockdown of mDia1 expression also reduces cortactin expression in malignant glioma cells (23) , it is possible that mDia1 modulates MMP-2 and MMP-9 secretion via regulation of cortactin expression. In addition, results from the present study demonstrate that expression of MMP-2 is associated with breast cancer cell invasion induced by mDia1-CA (Fig. 2C) . Although mDia1 and cortactin are important proteins for invasion in various cells, the detailed mechanism underlying the regulation of MMP secretion by mDia1 and cortactin requires further elucidation; this regulation may be cell type-and context-dependent.
MMP-2 and MMP-9 are highly linked to invasion of cancer cells, including breast cancer cells; however, the relative importance of MMPs for breast cancer cell invasion remains controversial (24) (25) (26) . Although such effects may depend on experimental conditions, results from the present study demonstrated that increased invasion via mDia1-CA overexpression is specifically inhibited by knocking down MMP-2, while the effect of MMP-9 knockdown was not marked (Fig. 2C) . These results suggest that MMP-2 and MMP-9 were involved in breast cancer cell activity; however, MMP-2 may be a major proteinase regulator of breast cancer cell invasion induced by mDia1.
In conclusion, the mDia1 protein expression level is elevated in a number of types of cancer, including kidney, prostate, and breast cancer. Overexpression of mDia1-CA promoted invasion of MDA-MB-231 cells, which was reduced by the addition of an MMP inhibitor. In addition, invasion induced by overexpression of mDia1-CA was significantly decreased by silencing MMP-2. Furthermore, overexpression of mDia1-CA induced invasion of MCF-7 cells due to increased MMP-2 activity. Results from the present study suggested that mDia1 is an important regulator of breast cancer cell invasion and that its effects may be mediated by MMP-2 activity.
